$ARTH Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in Arch Therapeutics, Inc..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of all insider trading transactions in Arch Therapeutics, Inc.. Get notifications about new insider transactions in Arch Therapeutics, Inc. for free.
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Jun 23 2020 | ARTH | Arch Therapeutics, ... | SULAT JAMES R | Director | Option Exercise | P | 0.25 | 340,910 | 85,228 | 340,910 | |
| Jun 23 2020 | ARTH | Arch Therapeutics, ... | SULAT JAMES R | Director | Option Exercise | O | 0.18 | 454,546 | 81,818 | 0 | |
| Jun 23 2020 | ARTH | Arch Therapeutics, ... | SULAT JAMES R | Director | Buy | O | 81,818.30 | 454,546 | 37,190,171,901 | 1,376,813 | 922.3 K to 1.4 M (+49.29 %) |
| Dec 23 2019 | ARTH | Arch Therapeutics, ... | Norchi Terrence W | President & CEO | Option Exercise | A | 0.23 | 1,000,000 | 229,200 | 1,000,000 | |
| Dec 23 2019 | ARTH | Arch Therapeutics, ... | DAVIS RICHARD E | CFO & Treasurer | Option Exercise | A | 0.23 | 700,000 | 160,440 | 700,000 | |
| Dec 23 2019 | ARTH | Arch Therapeutics, ... | SULAT JAMES R | Director | Option Exercise | A | 0.23 | 300,000 | 68,760 | 300,000 | |
| Dec 23 2019 | ARTH | Arch Therapeutics, ... | DHILLON PUNIT | Director | Option Exercise | A | 0.23 | 300,000 | 68,760 | 300,000 | |
| Jul 20 2018 | ARTH | Arch Therapeutics, ... | SULAT JAMES R | Director | Option Exercise | A | 0.43 | 110,000 | 46,750 | 110,000 | |
| Jul 20 2018 | ARTH | Arch Therapeutics, ... | SULAT JAMES R | Director | Grant | A | 0.00 | 110,000 | 0 | 370,000 | 260 K to 370 K (+42.31 %) |
| Jul 20 2018 | ARTH | Arch Therapeutics, ... | Norchi Terrence W | President & CEO | Option Exercise | A | 0.43 | 360,000 | 153,000 | 360,000 | |
| Jul 20 2018 | ARTH | Arch Therapeutics, ... | Norchi Terrence W | President & CEO | Grant | A | 0.00 | 360,000 | 0 | 3,559,076 | 3.2 M to 3.6 M (+11.25 %) |
| Jul 20 2018 | ARTH | Arch Therapeutics, ... | DAVIS RICHARD E | CFO & Treasurer | Option Exercise | A | 0.43 | 275,000 | 116,875 | 275,000 | |
| Jul 20 2018 | ARTH | Arch Therapeutics, ... | DAVIS RICHARD E | CFO & Treasurer | Grant | A | 0.00 | 275,000 | 0 | 878,000 | 603 K to 878 K (+45.61 %) |
| Jul 20 2018 | ARTH | Arch Therapeutics, ... | DHILLON PUNIT | Director | Option Exercise | A | 0.43 | 200,000 | 85,000 | 200,000 | |
| Jul 20 2018 | ARTH | Arch Therapeutics, ... | DHILLON AVTAR S | Director | Option Exercise | A | 0.43 | 220,000 | 93,500 | 220,000 | |
| Jul 20 2018 | ARTH | Arch Therapeutics, ... | DHILLON AVTAR S | Director | Grant | A | 0.00 | 220,000 | 0 | 8,517,373 | 8.3 M to 8.5 M (+2.65 %) |
| Jul 18 2018 | ARTH | Arch Therapeutics, ... | SULAT JAMES R | Director | Option Exercise | M | 0.37 | 30,000 | 11,100 | 0 | |
| Jul 18 2018 | ARTH | Arch Therapeutics, ... | SULAT JAMES R | Director | Buy | M | 0.37 | 30,000 | 11,100 | 260,000 | 230 K to 260 K (+13.04 %) |
| Feb 06 2017 | ARTH | Arch Therapeutics, ... | SULAT JAMES R | Director | Option Exercise | A | 0.65 | 200,000 | 130,000 | 200,000 | |
| Feb 06 2017 | ARTH | Arch Therapeutics, ... | SULAT JAMES R | Director | Grant | A | 0.00 | 200,000 | 0 | 230,000 | 30 K to 230 K (+666.67 %) |
| Feb 06 2017 | ARTH | Arch Therapeutics, ... | Norchi Terrence W | President & CEO | Option Exercise | A | 0.65 | 650,000 | 422,500 | 650,000 | |
| Feb 06 2017 | ARTH | Arch Therapeutics, ... | Norchi Terrence W | President & CEO | Grant | A | 0.00 | 650,000 | 0 | 3,199,076 | 2.5 M to 3.2 M (+25.50 %) |
| Feb 06 2017 | ARTH | Arch Therapeutics, ... | DHILLON AVTAR S | Director | Option Exercise | A | 0.65 | 400,000 | 260,000 | 400,000 | |
| Feb 06 2017 | ARTH | Arch Therapeutics, ... | DHILLON AVTAR S | Director | Grant | A | 0.00 | 400,000 | 0 | 8,297,373 | 7.9 M to 8.3 M (+5.06 %) |
| Feb 06 2017 | ARTH | Arch Therapeutics, ... | DAVIS RICHARD E | CFO & Treasurer | Option Exercise | A | 0.65 | 500,000 | 325,000 | 500,000 | |
| Feb 06 2017 | ARTH | Arch Therapeutics, ... | DAVIS RICHARD E | CFO & Treasurer | Grant | A | 0.00 | 500,000 | 0 | 603,000 | 103 K to 603 K (+485.44 %) |
| May 31 2016 | ARTH | Arch Therapeutics, ... | SULAT JAMES R | Director | Option Exercise | P | 0.44 | 83,333 | 36,500 | 83,333 | |
| May 31 2016 | ARTH | Arch Therapeutics, ... | SULAT JAMES R | Director | Buy | P | 0.00 | 111,111 | 0 | 868,934 | 757.8 K to 868.9 K (+14.66 %) |
| May 05 2016 | ARTH | Arch Therapeutics, ... | Norchi Terrence W | President & CEO | Option Exercise | A | 0.39 | 1,250,000 | 487,500 | 1,250,000 | |
| May 05 2016 | ARTH | Arch Therapeutics, ... | Norchi Terrence W | President & CEO | Grant | A | 0.00 | 1,130,000 | 0 | 2,549,076 | 1.4 M to 2.5 M (+79.63 %) |
| May 05 2016 | ARTH | Arch Therapeutics, ... | DAVIS RICHARD E | CFO & Treasurer | Option Exercise | A | 0.39 | 150,000 | 58,500 | 150,000 | |
| May 05 2016 | ARTH | Arch Therapeutics, ... | DAVIS RICHARD E | CFO & Treasurer | Grant | A | 0.00 | 103,000 | 0 | 103,000 | 0 to 103 K |
| May 05 2016 | ARTH | Arch Therapeutics, ... | SULAT JAMES R | Director | Option Exercise | A | 0.39 | 130,000 | 50,700 | 130,000 | |
| May 05 2016 | ARTH | Arch Therapeutics, ... | SULAT JAMES R | Director | Grant | A | 0.00 | 30,000 | 0 | 30,000 | 0 to 30 K |
| May 05 2016 | ARTH | Arch Therapeutics, ... | DHILLON AVTAR S | Director | Option Exercise | A | 0.39 | 830,000 | 323,700 | 830,000 | |
| May 05 2016 | ARTH | Arch Therapeutics, ... | DHILLON AVTAR S | Director | Grant | A | 0.00 | 737,000 | 0 | 7,897,373 | 7.2 M to 7.9 M (+10.29 %) |
| Aug 20 2015 | ARTH | Arch Therapeutics, ... | SULAT JAMES R | Director | Option Exercise | A | 0.27 | 200,000 | 54,000 | 200,000 | |
| Aug 19 2015 | ARTH | Arch Therapeutics, ... | DHILLON AVTAR S | Director | Option Exercise | A | 0.28 | 355,000 | 99,400 | 355,000 | |
| Aug 19 2015 | ARTH | Arch Therapeutics, ... | DAVIS RICHARD E | CFO & TREASURER | Option Exercise | A | 0.28 | 175,000 | 49,000 | 175,000 | |
| Aug 19 2015 | ARTH | Arch Therapeutics, ... | Norchi Terrence W | President, CEO | Option Exercise | A | 0.28 | 355,000 | 99,400 | 355,000 | |
| Jan 23 2015 | ARTH | Arch Therapeutics, ... | DAVIS RICHARD E | CFO & TREASURER | Option Exercise | A | 0.19 | 500,000 | 95,000 | 500,000 | |
| Jan 23 2015 | ARTH | Arch Therapeutics, ... | Norchi Terrence W | President & CEO | Option Exercise | A | 0.19 | 400,000 | 76,000 | 400,000 | |
| Jan 23 2015 | ARTH | Arch Therapeutics, ... | ROSENTHAL ARTHUR L | Director | Option Exercise | A | 0.19 | 100,000 | 19,000 | 100,000 | |
| Jan 23 2015 | ARTH | Arch Therapeutics, ... | DHILLON AVTAR S | Director | Option Exercise | A | 0.19 | 400,000 | 76,000 | 400,000 | |
| Jul 08 2014 | ARTH | Arch Therapeutics, ... | DAVIS RICHARD E | CFO & TREASURER | Option Exercise | A | 0.22 | 500,000 | 110,000 | 500,000 | |
| Mar 25 2014 | ARTH | Arch Therapeutics, ... | Norchi Terrence W | See Remarks | Option Exercise | A | 0.35 | 500,000 | 175,000 | 500,000 | |
| Mar 25 2014 | ARTH | Arch Therapeutics, ... | COTTER WILLIAM M | Chief Operating Off ... | Option Exercise | A | 0.35 | 350,000 | 122,500 | 350,000 | |
| Mar 25 2014 | ARTH | Arch Therapeutics, ... | DHILLON AVTAR S | Director | Option Exercise | A | 0.35 | 200,000 | 70,000 | 200,000 | |
| Mar 25 2014 | ARTH | Arch Therapeutics, ... | ROSENTHAL ARTHUR L | Director | Option Exercise | A | 0.35 | 200,000 | 70,000 | 200,000 | |
| Sep 11 2013 | ARTH | Arch Therapeutics, ... | Barber Alan | Chief Financial Off ... | Option Exercise | A | 0.40 | 125,000 | 50,000 | 125,000 | |
| Sep 11 2013 | ARTH | Arch Therapeutics, ... | COTTER WILLIAM M | Chief Operating Off ... | Option Exercise | A | 0.40 | 250,000 | 100,000 | 250,000 | |
| Jun 26 2013 | ARTH | Arch Therapeutics, ... | Norchi Terrence W | Pres, CEO, Sec, and ... | Buy | J | 0.00 | 1,419,076 | 0 | 1,419,076 | 0 to 1.4 M |
| Jun 26 2013 | ARTH | Arch Therapeutics, ... | DHILLON AVTAR S | Director | Buy | J | 0.00 | 160,373 | 0 | 7,160,373 | 7 M to 7.2 M (+2.29 %) |
Page: 1